Processa Pharmaceuticals (PCSA) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($4.2 million vs $4.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | PCSA | RDHL |
|---|---|---|
| Share price | $1.42 | $0.474 |
| Market cap | $3.97M | $4.21M |
| 1-day change | -5.96% | -2.07% |
| Forward P/E | — | 15.80 |
| EPS (TTM) | $-4.33 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.08 | $2.14 |
| 52-week low | $1.41 | $0.465 |
| Distance from 52-week high | -87.18% | -77.85% |
| Average volume | 228.15K | 1.84M |
| Shares outstanding | 2.79M | 8.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PCSA vs RDHL FAQ
Which is bigger, Processa Pharmaceuticals or Redhill Biopharma?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $4.21M compared with $3.97M for Processa Pharmaceuticals (PCSA).
Are Processa Pharmaceuticals and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.